Acadia Pharmaceuticals Inc. logo

Acadia Pharmaceuticals Inc. (ACAD)

$14.92

Acadia Pharmaceuticals Inc. (ACAD) Share Price Forecast
Currently 26 wall-street analysts regularly analyze the financials of Acadia Pharmaceuticals Inc. on a frequent basis to provide recommendations along with target share price. 26 analysts offering 12-month price forecasts for Acadia Pharmaceuticals Inc. (ACAD) have a share price target of $25.28. This median of share price forecast represents a 69.44% upside from the latest price of $14.92 as on 15.10.24.

Acadia Pharmaceuticals Inc. (ACAD) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Acadia Pharmaceuticals Inc. (ACAD) share price will touch around $25.28 in next 12-months.
Acadia Pharmaceuticals Inc. (ACAD) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Acadia Pharmaceuticals Inc.'s share price and its median forecast price. As on 15.10.24, the difference is -39.48%

Acadia Pharmaceuticals Inc. (ACAD): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Acadia Pharmaceuticals Inc. (ACAD) Share Price : Analyst Recommendation
Based on 26 analysts tracking and researching Acadia Pharmaceuticals Inc. (ACAD) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
14
13
13
Outperform
6
6
6
Hold
6
7
6
Underperform
0
0
0
Sell
1
1
1
Acadia Pharmaceuticals Inc. (ACAD) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Acadia Pharmaceuticals Inc. (ACAD) is $25.28, offered by 26 analysts offering 12-month price forecasts.

Acadia Pharmaceuticals Inc. (ACAD) has a maximum of 0.69 upside potential, based on 26 analysts offering 12-month price forecasts.

Based on 26 analysts tracking and researching Acadia Pharmaceuticals Inc. (ACAD), 73.08% have a buy recommendation. Remaining 26.92% have either sell or hold recommendations.

The latest share price of Acadia Pharmaceuticals Inc. (ACAD) is $14.92 as of 15/10/2024.

19 of total 26 analysts offering stock ratings for Acadia Pharmaceuticals Inc. ACAD have recommended buy rating.